Molecular diversity of serial Cryptococcus neoformans isolates from AIDS patients in the city of São Paulo, Brazil

Memorias do Instituto Oswaldo Cruz

Volumn 102, Issue 7, 2007, Pages 777-784

  Martins, Marilena A ^a   Pappalardo, Mara C S M ^b   Melhem, Márcia S C ^a   Pereira Chioccola, Vera L ^a  

^a INSTITUTO ADOLFO LUTZ   (Brazil)

^b INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS   (Brazil)

Author keywords

Cryptococcal meningoencephalitis and AIDS; Molecular analysis of Cryptococcus neoformans isolates

Indexed keywords

FILOBASIDIELLA NEOFORMANS;

EID: 37049039694     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762007000700001     Document Type: Article

References (48)

1. Almeida AM, Matsumoto MT, Baeza LC, de Oliveira E, Silva RB, Kleiner AA, Melhem MS, Mendes Giannini MJ, Laboratory Group on Cryptococcosis 2007. Molecular typing and antifungal susceptibility of clinical sequential isolates of Cryptococcus neoformans from São Paulo State, Brazil. FEMS Yeast Res 7: 152-164.
2. Barchiesi F, Hollis RJ, Messer SA, Scalise G, Rinaldi MG, Pfaller MA 1995. Electrophoretic karyotype and in vitro antifungal susceptibility of Cryptococcus neoformans isolates of Aids patients. Diagn Microbiol Infect Dis 23: 99-103.
3. Barreto de Oliveira MT, Boekhout T, Theelen B, Hagen F, Baroni FA, Lazera MS, Lengeler KB, Heitman J, Rivera ING, Paula CR 2004. Cryptococcus neoformans shows a remarkable genotypic diversity in Brazil. J Clin Microbiol 42: 1356-1359.
4. Calvo B, Fischman O, Pignatari A, Del Bianco R, Zaror L 1990. Variedades y serotipos de Cryptococcus neoformans en pacientes con sida y neurocriptococosis en São Paulo, Brasil. Rev Inst Med Trop São Paulo 32: 480-482.
5. Calvo BM, Colombo AL, Fischman O, Santiago A, Thompson L, Lazera MS, Telles F, Fukushima K, Nishimura K, Tanaka R, Myiajy M, Moretti-Branchini ML 2001. Antifungal susceptibilities, varieties, and electrophoretic karyotypes of clinical isolates of Cryptococcus neoformans from Brazil, Chile, and Venezuela. J Clin Microbiol 39: 2348-2350.
6. Cavalcante SC, Freitas RS, Vidal MSM, Dantas KC, Levi JE, Martins JEC 2007. Evaluation of phenotypic and genotypic alterations induced by long periods of subculturing of Cryptococcus neoformans strains. Mem Inst Oswaldo Cruz 102: 41-47.
7. CDC- Center for Disease Control 1999. Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. MMWR 48 (RR-13) p. 1-28; [cited 2006 Dec 12]. Available from: http://nursingworld.org/ AJN/2002/june/Wawatch.htm.
8. Chen LC, Goldman DL, Doering TL 1999. Antibody response to Cryptococcus infection proteins in rodents and human. Infect Immunol 67: 2218-2224.
9. Chen SCA, Brownlee AG, Sorrell TC, Ruma P, Ellis DH, Pfeiffer T, Speed BR, Nimmo G 1996. Identification by random amplification of polymorphic DNA of a common molecular type of Cryptococcus neoformans var neoformans in patients with Aids or other immunosupressive conditions. J Infec Dis 173: 754-758.
10. Currie BP, Freundlich LF, Casadevall A 1994. Restriction fragment lenght polymorphism analysis of isolates from Cryptococcus neoformans enviromental (pigeon excreta) and clinical sources in New York city. J Clin Microbiol 34: 1188-1192.
11. Dufait R, Velho R, De Vroey C 1987. Rapid identification of the two varieties of by D-proline assimilation. Mycoses 30: 482.
12. Ellis DH, Pfeiffer TJ 1990. Ecology, life cycle and infectious propagule of Cryptococcus neoformans. Lancet 336: 923-925.
13. Franzot SP, Hamdan JS, Currie BP, Casadevall A 1997. Molecular epidemiology of Cryptococcus neoformans in Brazil and the United States: evidence for both local genetic differences and a global clonal population structure. J Clin Microbiol 35: 2243-2251.
14. Franzot SP, Mukherjee J, Cherniak R, Chen LC, Hamdan JS, Casadevall A 1998. Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes. Infect Immun 66: 89-97
15. Franzot SP, Salkin IF, Casadevall A 1999. Cryptococcus neoformans var. grubii: separate varietals status for serotype A isolates. J Clin Microbiol 37: 838-840.
16. García-Bermejo MJ, Antón J, Ferrer C, Mesegure I, Abad JL, Colom MF 2001. Chromosome lenght polymorphism in clinical and environmental isolates. Rev Iberoam Micol 18: 174-179.
17. Garcia-Hermoso MJ, Janbon D, Dromer F 1999. Epidemiological evidence for dormant Cryptococcus neoformans infection. J Clin Microbiol 37: 3204-3209.
18. Haynes KA, Sullivan DJ, Coleman DC, Clarke JC, Emilianus R, Atkinson C, Cann KJ 1995. Involvement of multiple Cryptococcus neoformans strains in a single episode of Cryptococcosis and reinfection with novel strains in recurrent infection demonstrated by random amplification of polymorphic DNA and DNA fingerprinting. J Clin Microbiol 33: 99-102.
19. Horta JA, Staats CC, Casali AK, Ribeiro AM, Schrank IS, Scharank A, Vainstein MH 2002. Epidemiological aspects of clinical and environmental Cryptococcus neoformans isolates in the Brazilian state Rio Grande do Sul. Med Mycol 40: 565-571.
20. Igreja RP, Lazera MS, Wanke B, Galhardo MCG, Kidd SE, Meyer W 2004. Molecular epidemiology of Cryptococcus neoformans isolates from AIDS patients of the Brazilian city, Rio de Janeiro. Med Mycol 42: 229-238.
21. Ikeda R, Nishikawa A, Shinoda T, Fukazawa Y 1985. Chemical characterization of capsular polysaccharide from Cryptococcus neoformans serotype A-D. Microbiol Immunol 29: 981-991.
22. Jain N, Wickes BL, Keller SM, Fu J, Casadevall A, Jain P, Ragan MA, Banerjee U, Fries BC 2005. Molecular Epidemiology of Clinical Cryptococcus neoformans Strains from India. J Clin Microbiol 43: 5733-5742.
23. Klepser ME, Pfaller MA 1998. Variation in electrophoretic karyotipe and antifungal susceptibility of clinical isolates of Cryptococcus neoformans at a university-affiliated teaching hospital from 1987 to 1994. J Clin Microbiol 36: 3653-3656.
24. Kwon-Chung KJ 1998. Cryptococcus. In CP Kurtzman, JW Fell, The yeasts: a taxonomic study, Elsevier, Amsterdam, p. 656-662.
25. Kwon-Chung KJ, Bennett JE 1992. Cryptococcosis. In KJ Kwon-Chung, JE Bennett, Medical Mycology, Lea & Febiger, Philadelphia, p. 397-446.
26. Kwon-Chung KJ, Varma SA 2006. Do major species concepts support one, two or more species within Cryptococcus neoformans? FEMS Yeast Res 6: 574-587.
27. Litvintseva AP, Thakur R, Vilgalys R , Mitchell TG 2006. Multilocus sequence typing reveals three genetic subpopulations of Cryptococcus neoformans var. grubii (serotype A), including a unique population in Botswana. Genetics 172: 2223-2238.
28. Loftus BJ, Fung E, Roncaglia P, Rowley D, Amedeo P, Bruno D, Vamathevan J, Miranda M, Anderson IJ, Fraser JA, Allen JE, Bosdet IE, Brent MR, Chiu R, Doering TL, Donlin MJ, D'Souza CA, Fox DS, Grinberg V, Fu J, Fukushima M, Haas BJ, Huang JC, Janbon G, Jones SJ, Koo HL, Krzywinski MI, Kwon-Chung JK, Lengeler KB, Maiti R, Marra MA, Marra RE, Mathewson CA, Mitchell TG, Pertea M, Riggs FR, Salzberg SL, Schein JE, Shvartsbeyn A, Shin H, Shumway M, Specht CA, Suh BB, Tenney A, Utterback TR, Wickes BL, Wortman JR, Wye NH, Kronstad JW, Lodge JK, Heitman J, Davis RW, Fraser CM, Hyman RW 2005. The genome of the basidiomycetous yeast and human pathogen Cryptococcus neoformans. Sience 307: 1321-1324.
29. Meyer W, Marszewska K, Amirmostofian M, Igreja RP, Hardtke C, Methling K, Viviani MA, Chindamporn A, Sukroongreung S, John MA, Ellis DH, Sorrell TC 1999. Molecular typing of global isolates of Cryptococcus neoformans var. neoformans by polymerase chain reaction fingerprinting and randomly amplified polymorphic DNA - a pilot study to standardize techniques on which to base a detailed epidemiological survey. Electrophoresis 20: 1790-1799.
30. Mitchell TG, Perfect PT 1995. Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 8: 515-548.
31. Montenegro H, Paula CR 2000. Environmental isolation of Cryptococcus neoformans var. gattii and C. neoformans var. neoformans in the city of São Paulo, Brazil. Med Mycol 38: 385-390.
32. Nishikawa MM, Lazera MS, Barbosa GG, Trilles L, Balassiano BR, Macedo RCL, Bezerra CCF, Perez MA, Cardarelli P, Wanke B 2003. Serotyping of 467 Cryptococcus neoformans isolates from clinical and environmental sources in Brazil: analysis of host and regional patterns. J Clin Microbiol 41: 73-77.
33. Oliveira JF, Greco DB, Oliveira GC, Christo PP, Guimarães MD, Oliveira RC 2006. Neurological disease in HIV-infected patients in the era of highly active antiretroviral treatment: a Brazilian experience. Rev Soc Bras Med Trop 39: 146-151.
34. Pappalardo MC, Melhem MS 2003. Cryptococcosis: a review of the Brazilian experience for the disease. Rev Inst Med Trop São Paulo 45: 299-305.
35. Perfect JR, Magee BB, Magee PT 1989. Separation of chromosomes of Cryptococcus neoformans by pulsed field gel electrophoresis. Infect Immun 57: 2624-2627.
36. Perfect JR, Casadevall A 2002. Cryptococcosis. Infect Dis Clin North Am 16: 837-874.
37. Pfaller MA, Messer SA, Boyken L, Rice C, Tendolkar S, Hollis RJ, Doern GV, Diekema DJ 2005. Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004). J Clin Microbiol 43: 2163-2167.
38. Sacktor N 2002. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly antiretroviral therapy. J Neurovirol 8: 115-121.
39. Sambrook J, Fritsch EF, Maniatis T 1989. Commonly used techniques in molecular cloning. In J Sambrook, EF Fritsch, T Maniatis, Molecular cloning. A laboratory manual, appendix E, Cold Spring Harbour Laboratory Press, New York, p. 3-6.
40. Santos NJS, Tayra A, Silva SR, Buchalla CM, Laurenti R 2002. AIDS in the State of São Paulo. Changes in the profile of the epidemic and prospects for epidemiological surveillance. Rev Bras Epidemiol 5: 286-310.
41. Saag MS, Powderly WG, Cloud GA, Robinson P, Grieco MH, Sharkey PK, Thompson SE, Sugar AM, Tuazon CU, Fisher JF, Hyslop N, Jacobson JM, Hafner R, Dismukes WE 1992. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. New Engl J Med 326: 83-89.
42. Schimpff SC, Bennett JE 1975. Abnormalities in cell-mediated immunity in patients with Cryptococcus neoformans infection. J Allergy Clin Immunol 55: 430-441.
43. Silva MT, Araujo A 2005. Highly active antiretroviral therapy access and neurological complications of human immunodeficiency virus infection: Impact versus resources in Brazil. J Neurovirol 11: 11-15.
44. Soll DR 2000. The ins and outs of DNA fingerprinting the infectious fungi. Clin Microbiol Rev 13: 332-370.
45. Sukroongreung S, Lim S, Tantimavanich S, Eampokalap B, Carter D, Nilakui C, Kulderatiyut S, Tanshyphaswadikui S 2001. Phenotypic switching and genetic diversity of Cryptococcus neoformans. J Clin Microbiol 39: 2060-2064.
46. Sullivan D, Haynes K, Moran G, Shanley D, Coleman D 1996. Persistence, replacement and microevolution of Cryptococcus neoformans strains in recurrent meningitis in AIDS Patients. J Clin Microbiol 34: 1739-1744.
47. Tibayrec M 1996. Towards a unified evolutionary genetics of microorganisms. Ann Rev Microbiol 50: 401-429.
48. Wickes BL, Moore TDE, Kwon-Chung KJ 1994. Comparison of the electrophoretic karyotypes and chromosomal location of ten genes in the two varieties of Cryptococcus neoformans. Microbiol 140: 543-550.